Almonty's Russell Entry Sparks Sell-Off Despite $700 Million Capital Injection
Published on 07/04/2026 at 18:23 | Redaktion boerse-global.de
The tungsten producer Almonty Industries joined the Russell 1000 and Russell 3000 on June 29, a milestone that typically triggers automatic buying from passive index funds. Instead, investors used the event to cash out, sending the stock down roughly 17 percent over the past month. The shares closed at C$23.14 on Friday, sliding below their 50-day moving average of C$26.10.
The decline takes the edge off what has been a staggering run. The stock has still gained 92 percent since the start of the year and has nearly quadrupled from its 52-week low of C$4.70 set on July 29 last year. Yet the annualized 30-day volatility stands at 90.65 percent, underscoring just how violently the shares can swing on any news.
Management's Make-or-Break Moment
Almonty's near-term fate hinges on the Sangdong processing plant, which has just moved from construction into operations. The company has already stockpiled a sizable ore inventory — enough to cover roughly 2.6 months of initial production, with an embedded tungsten value of about $68 million at current prices. The challenge now is turning that stockpile into revenue.
"The management must now demonstrate that the new plant works reliably," one source close to the company noted. If the ore flows through the mill without major hiccups, operating losses should shrink rapidly. If not, the stock risks giving back a chunk of its recent gains.
Should investors sell immediately? Or is it worth buying Almonty?
Analyst Sentiment Turns Bitterly Divided
Wall Street is deeply split on Almonty's prospects. A consensus of analysts places the median price target at C$35.29, implying roughly 52 percent upside from Friday's close. But the breakdown tells a different story: 68 percent of surveyed analysts rate the stock a sell, while only 29 percent recommend buying. One individual rating sets the target as low as C$25 — barely above the current price.
Balance Sheet Gets a Massive Boost
Critically, Almonty fortified its finances in parallel with the index entry. The company placed an oversubscribed $700 million convertible note offering carrying a 2.25 percent coupon and maturing in 2031, sold exclusively to qualified institutional buyers. Initial purchasers also received an option to buy up to an additional $100 million in notes.
Roughly $83 million of the net proceeds will go into capped-call transactions to limit dilution from the conversion. Another $50 million is earmarked for refinancing existing debt. The lion's share — some $543 million — is destined for working capital and general corporate purposes, including potential acquisitions.
This capital injection arrives as the operating picture brightens. First-quarter 2026 revenue surged 221 percent year-over-year to $25.4 million, compared with $7.9 million in the same period a year ago. The net loss narrowed dramatically from $34.6 million to $5.3 million. Operating cash flow swung to a positive $9.7 million from negative $4.4 million. As of March 31, Almonty held $259.9 million in cash and $169.5 million in working capital.
Insider Activity Remains Routine
Separate filings with the Australian Securities Exchange revealed that three directors — Daniel D'Amato, Gustave F. Perna and Mark Trachuk — received share-based compensation on July 1, all without any cash outlay. D'Amato and Trachuk were awarded deferred share units, while Perna had restricted share units converted into common stock. The simultaneous timing across the board suggests a routine compensation cycle rather than any discretionary event. No insider sales were reported on the open market.
Almonty at a turning point? This analysis reveals what investors need to know now.
Technical Picture Shows a Breather
The stock now trades 11.33 percent below its 50-day average but still 26.14 percent above its 200-day moving average of C$18.34. That combination describes a long-term uptrend that has taken a short-term pause. The relative strength index sits at 43.4, indicating neither overbought nor oversold conditions.
Whether the Russell inclusion and the fresh convertible cash will trigger sustained institutional buying remains an open question. After a twelve-month rally of 245.89 percent, the shares are clearly due for a consolidation phase. The next few weeks will reveal whether Sangdong's ore stack can start generating the cash that the balance sheet now says it should.
Ad
Almonty Stock: New Analysis - 4 July
Fresh Almonty information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
